Neurologists, Neuroscientists, Pathologists, Surgeons, Vascular Medicine Specialists, Vascular Surgeons
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is an exciting new initiative. It represents a timely expansion of the journal Amyotrophic Lateral Sclerosis in response to the clinical, imaging pathological and genetic overlap between ALS and frontotemporal dementia. The expanded journal provides outstanding coverage of research in a wide range of issues related to motor neuron diseases, especially ALS (Lou Gehrig’s disease) and cognitive decline associated with frontotemporal degeneration. The journal also covers related disorders of the neuroaxis when relevant to these core conditions. The Editorial Board comprises key opinion leaders in ALS and FTD. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration aims to disseminate information on new developments in the pathogenesis and management of ALS and FTD, and enhance awareness of these devastating and often under-recognised disorders. The Editors encourage submission of original research, case reports and short reports on all aspects of ALS, frontotemporal dementia and related conditions, including basic science, genetics, new treatments, clinical trials, epidemiology, clinical neurophysiology, and other clinical and scientific aspects. Features include: In-depth reviews, Original research, Basic science, Epidemiology, Clinical trials, Care issues, Ethics and legal issues, Health economics, Case reports, Point-Counterpoint debate, Correspondence, Book reviews, ALS centre reports.
World Federation of Neurology Research Group on Motor Neuron Disease (WFN MND)